Imageless Navigation Versus Image-Based Navigation in Robotic-Assisted Total Knee Arthroplasty for Knee Osteoarthritis
Outcomes of Robotic-Assisted Total Knee Arthroplasty With Imageless Navigation Versus Image-Based Navigation: A Randomised, Single-Blinded, Non-Inferiority Trial
1 other identifier
interventional
146
1 country
1
Brief Summary
The goal of this clinical trial is to learn if imageless navigation is not inferior to image-based navigation in robotic-assisted total knee arthroplasty (RA-TKA) for treating patients with knee osteoarthritis. The main questions the study aims to answer are:
- 1.Does imageless procedure provide functional results comparable to those of image-based navigation?
- 2.Are there differences in postoperative complications patients may experience after RA-TKA with imageless and image-based navigation? Researchers will compare imageless navigation with image-based navigation used in total knee arthroplasty to assess whether imageless navigation is comparable for the treatment of knee osteoarthritis.
- 3.Answer survey questions about knee pain and function before RA-TKA.
- 4.Undergo RA-TKA with imageless navigation or image-based navigation.
- 5.Visit the Clinic after 6 months and 12 months after surgery for checkups and to answer the same survey questions about postoperative knee pain and function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2029
April 13, 2026
April 1, 2026
2.7 years
March 30, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient-Reported Outcome Measures assessed with the Oxford Knee Score
Zero is equivalent to the worst possible function of the joint and 48 indicates the best achievable function.
Survey taken right before surgery, at 6 months, and at 12 months after surgery.
Secondary Outcomes (9)
Number of Participants achieving a planned postoperative limb alignment
From enrollment to 12 months after surgery.
Postoperative radiographic results
From enrollment to 12 months after surgery.
Postoperative pain assessed with a VAS scale
Survey taken right before surgery, at 6 months, and at 12 months after surgery.
Time of the surgical procedure
From the beginning to the end of the surgical procedure.
Estimation of perioperative blood loss
Immediately after the end of the surgery.
- +4 more secondary outcomes
Study Arms (2)
Imageless Robotic Navigation
ACTIVE COMPARATORImage-based Robotic Navigation
ACTIVE COMPARATORInterventions
Patients undergoing Robotic-Assisted Total Knee Arthroplasty with Imageless Navigation
Patients undergoing Robotic-Assisted Total Knee Arthroplasty with Image-based Navigation
Eligibility Criteria
You may qualify if:
- Symptomatic, radiologically confirmed advanced osteoarthritis of the knee.
- Patients referred for primary robotic-assisted total knee arthroplasty.
- Patients in whom a correctly performed radiograph with designated sensors has confirmed the possibility of performing robotic-assisted total knee arthroplasty with image-based navigation.
- Patients capable of giving informed consent to participate in the study and willing to attend all follow-up visits.
You may not qualify if:
- No informed consent for the surgery.
- No informed consent for taking part in the study.
- Pregnancy.
- Active infections.
- Diagnosed comorbidities: autoimmune arthritis, malignant tumors, serious neurological disorders affecting a reliable functional outcome measurement (e.g., severe stroke, severe Parkinson's disease).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Orthopedics and Locomotor Traumatology, Medical University of Warsaw
Warsaw, Mazovian, 02-005, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paweł Łęgosz, MD, Professor
Medical University of Warsaw
- PRINCIPAL INVESTIGATOR
Łukasz Pulik, MD, PhD
Medical University of Warsaw
- PRINCIPAL INVESTIGATOR
Paweł Kasprzak, MD
Medical University of Warsaw
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 30, 2026
First Posted
April 13, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
January 1, 2029
Study Completion (Estimated)
January 1, 2029
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Within 12 months of the trial completion.
- Access Criteria
- Data and supporting information will be shared upon reasonable request to the Principal Investigator. After the Principal Investigator reviews and approves the applicant's request, de-identified information will be provided.
De-identified study results will be disseminated in conference abstracts and peer-reviewed journal articles.